The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results and biomarker analyses from the phase 2 trial of nab-paclitaxel plus sintilimab as second-line therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (G/GEJA).
 
Zhichao Jiang
No Relationships to Disclose
 
Wen Zhang
No Relationships to Disclose
 
Lin Yang
No Relationships to Disclose
 
Yongkun SUN
No Relationships to Disclose
 
Yun-Bo Zhao
No Relationships to Disclose
 
Wei Deng
No Relationships to Disclose
 
Liang Cui
No Relationships to Disclose
 
Aiping Zhou
No Relationships to Disclose